Skip to main content

Table 1 Community COVID-19 prevalence and asymptomatic carriage in pregnant women

From: Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review

Author

Region/Country

Type of study

Peak daily case load at start of the study period for relevant area

Max daily case load during study period for relevant area

Peak daily case load the end of the study period for relevant area

Number of pregnant women in study

Number tested positive

Number asymptomatic at the time of admission AND tested positive

Test positivity %

Proportion of asymptomatic test positive %

Fassett

California, USA

Observational retrospective study

1261

1921

1921

3923

17

17

0.43

100.00

Gagliardi

North of Tuscany and Liguria, Italy

Case series

5210

6153

4053

533

3

2

0.56

66.67

Herraiz

Madrid, Spain

Observational retrospective study

6278

6740

2610

203

2

1

0.99

50.00

Naqvi

California, USA

Case series

1104

1331

1268

82

1

0

1.22

0.00

LaCourse

Washington, USA

Retrospective cohort

2

437

314

188

5

1

2.66

20.00

Ceulemans

North East Flanders, Belgium

Case series

683

2319

426

470

13

8

2.77

61.54

Miller

Illinois, USA

Case series

1150

2023

2023

635

23

10

3.62

43.48

Ochiai

Tokyo, Japan

Retrospective analysis

383

743

203

52

2

2

3.85

100.00

Campbell

Connecticut, USA

Case series

377

1100

620

770

30

22

3.90

73.33

Khalil

London, UK

Cohort study

822

1071

434

129

9

8

6.98

88.89

Yassa

Istanbul, Turkey

Prospective cohort

2131

2936

1035

296

23

12

7.77

52.17

Prabhu

New York, USA

Prospective cohort

2166

9909

6693

675

70

55

10.37

78.57

Doria

Senhora da Hora, Portugal

Case series

302

1516

514

103

12

11

11.65

91.67

Sutton

New York, USA

Cohort study

2166

8775

8775

215

33

29

15.40

87.60

Buckley

New York, USA

Case series

9073

9909

8064

307

50

50

16.29

100.00

Vintzileos

New York, USA

Retrospective cohort

6555

9909

9410

161

32

21

19.88

65.63

London

New York, USA

Retrospective cohort

73

9909

8064

156

68

22

43.58

32.35

  1. Data presented are in ascending order of the total proportion of pregnant women who tested positive. Data for peak daily reported COVID-19 prevalence at the start, during and end of the relevant study periods were retrieved from internationally published repositories [30,31,32]. This data was used to generate Figs. 2 and 3. NP- Nasopharyngeal, OP- Oropharyngeal